These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32038982)

  • 21. Genetic Alterations and Transcriptional Expression of m
    Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
    Front Oncol; 2020; 10():900. PubMed ID: 32850303
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
    Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
    Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation regulator-based signature for predicting clear cell renal cell carcinoma prognosis.
    Gong W; Yang R; Wang Z
    Am J Transl Res; 2023; 15(4):2443-2459. PubMed ID: 37193150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators.
    Li L; Tan H; Zhou J; Hu F
    Sci Rep; 2023 Aug; 13(1):12645. PubMed ID: 37542141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis and verification of
    Yang Z; Peng B; Pan Y; Gu Y
    Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
    [No Abstract]   [Full Text] [Related]  

  • 28. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.
    Wei J; Qian Y; Tang Y; Ge X; Jiang K; Fang Y; Fu D; Kong X; Xiao Q; Ding K
    Onco Targets Ther; 2021; 14():413-426. PubMed ID: 33488096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions and prognostic values of m
    Liu Y; Guo X; Zhao M; Ao H; Leng X; Liu M; Wu C; Ma J; Zhu J
    J Cell Physiol; 2020 Sep; 235(9):6043-6057. PubMed ID: 32052446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma.
    Xu T; Gao S; Ruan H; Liu J; Liu Y; Liu D; Tong J; Shi J; Yang H; Chen K; Zhang X
    Front Genet; 2021; 12():609174. PubMed ID: 34122497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
    Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
    Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
    Zhu Z; He A; Lin L; Xu C; Cai T; Lin J
    J Cancer; 2020; 11(22):6591-6600. PubMed ID: 33046980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma.
    Huang Z; Kang W; Zhang Q
    Transl Cancer Res; 2022 Jun; 11(6):1576-1586. PubMed ID: 35836532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma.
    Wang J; Zhang C; He W; Gou X
    J Cell Biochem; 2019 Feb; 120(2):2576-2593. PubMed ID: 30278113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
    Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m
    Zhuang J; Lin C; Ye J
    J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m
    Chen L; Hu B; Song X; Wang L; Ju M; Li Z; Zhou C; Zhang M; Wei Q; Guan Q; Jiang L; Chen T; Wei M; Zhao L
    Front Oncol; 2021; 11():598017. PubMed ID: 33796449
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.